|
|
Meta analysis on the influence of traditional Chinese medicine treatment for the hemorheology indexes of patients with diabetic retinopathy |
CHEN Qiuye MA Yanyun TANG Hong |
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China |
|
|
Abstract Objective To compare the influence of traditional Chinese medicine treatment and single western medicine treatment for the hemorheology indexes of patients with diabetic retinopathy by meta analysis. Methods The databases of PubMed, Medline, CBM disc, Cochrane library, CNKI, VIP, Wanfang, China Master's Theses Full-text Database and proceedings of the academic conference were retrieved. The retrieval time limit was from January 2000 to October 2016. The related clinical randomized controlled trials were researched, and the enrolled literatures were taken quality assessment and data extraction, and Revman5.3 software was used to take Meta analysis. Results In total, 26 clinical randomized controlled trials and 2421 patients were enrolled, with 1307 cases in experimental group and 1114 cases in control group. The levels of whole high blood viscosity (200/s) (SMD = -0.63, 95%CI: -0.91 - -0.34, P < 0.01), whole low blood viscosity (5/s) (WMD = -0.76, 95%CI: -1.02 - -0.50, P < 0.01), plasma viscosity (SMD = -0.62, 95%CI: -1.02 - -0.22, P = 0.002), fibrinogen (SMD = -0.67, 95%CI: -0.80 - -0.54, P < 0.01), red blood cell aggregation index (SMD = -0.96, 95%CI: -1.46 - -0.47, P = 0.0001) in the experimental group were significantly lower than those of control group, the fundus changing curative effect (RR = 1.22, 95%CI: 1.17 - 1.28, P < 0.01) and TCM syndrome curative effect (RR = 1.55, 95%CI: 1.18 - 2.03, P = 0.002) were significantly better than those of control group. The whole middle blood viscosity (30/s) between two groups had no statistically significant difference (MD = -1.22, 95%CI: -2.66 - 0.21, P = 0.10). Sensitivity analysis showed that the results were stable and reliable. Conclusion Traditional Chinese medicine treatment can reduce the whole high blood viscosity (200/s), whole low blood viscosity (5/s), plasma viscosity, fibrinogen, erythrocyte aggregation index of patients with diabetic retinopathy, and improve the fundus changing curative effect and TCM syndrome curative effect, all of which are superior to those of single western medicine treatment, while it has no effect on the whole middle blood viscosity (30/s). This paper shows that traditional Chinese medicine treatment for diabetic retinopathy has certain creative effect, but the methodological quality remains to be further improved, which needs more high-quality randomized, double-blind, controlled literatures to confirm.
|
|
|
|
|
[1] 刘永瑞,吕洪,李丰,等.中西医结合治疗糖尿病视网膜病变临床观察[J].中国中医急症,2014,23(12):2320-2322.
[2] 孟艳娇,于秀辰.中医药治疗糖尿病视网膜病变进展[J].北京中医药大学学报:中医临床版,2011,18(2):38-40.
[3] Word Heath Origination. Definition diagnosis and classification ofdiabetes mellitus and its complication:Report of a WHO Consultation [R]. Geneva:WHO,1999.
[4] 第三届全国眼科学术会议.糖尿病性视网膜病变临床分期标准[J].中华眼科杂志,1985,21(2):113.
[5] 陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:778-779.
[6] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技术出版社,2002:312-316.
[7] 王家良,刘鸣,刘关键,等.循证医学[M].北京:人民卫生出版社,2001:178-190.
[8] 杨建华,喻谦,廖莉.糖复明颗粒治疗非增殖期糖尿病视网膜病变的临床研究[J].北京中医药,2012,31(3):195-198.
[9] 杨洁文,范红娟,赵自冰,等.健目冲剂对单纯性糖尿病视网膜病变患者血液流变性的影响[J].中国中医急症杂志,2009,18(8):1261-1262.
[10] 严京,高健生,接传红,等.密蒙花方改善早期糖尿病视网膜病变中医症状及其用药安全性的研究[J].北京中医药大学学报,2010,33(11):773-776.
[11] 熊静,彭清华,吴权龙,等.益气养阴活血利水法治疗单纯性糖尿病视网膜病变临床研究[J].中国中医眼科杂志,2009,19(6):311-315.
[12] 马维彪.益气养阴通络方联合西药治疗糖尿病视网膜病变58例临床观察[J].新中医,2016,48(9):47-49.
[13] 王巧凡,邱晓堂,汤爱灿.中西医结合治疗糖尿病视网膜病变临床观察[J].中国中医基础医学杂志,2013,19(7):805-807.
[14] 郭连川,郭庆贺.中药“清障明目胶囊”治疗糖尿病视网膜病变疗效观察[J].辽宁中医杂志,2005,32(10):1046-1047.
[15] 韩琦,田洪军.活血利水方治疗单纯型糖尿病视网膜病变临床疗效观察[J].中国民康医学,2013,25(10):58-59.
[16] 高辉,刘怀栋,李焕丽.中医玄府辨证治疗非增殖期糖尿病视网膜病变32例临床观察[J].中国煤炭工业医学杂志,2014,17(4):641-644.
[17] 庞朝善,杨赞章.凉血散瘀汤加味治疗非增殖期糖尿病视网膜病变的临床观察[J].中国中医眼科杂志,2013, 23(3):169-172.
[18] 于南南,程晓亮,林昶,等.血栓通治疗2型糖尿病视网膜病变的疗效观察[J].实用糖尿病杂志,2011,7(1):54-55.
[19] 张云贵.血栓通治疗2型糖尿病视网膜病变的疗效观察[J].世界最新医学信息文摘,2015,15(31):68-69.
[20] 肖家翔,姚贤凤.养阴行血方对单纯型糖尿病视网膜病变微循环影响的临床研究[J].辽宁中医杂志,2013,40(4):718-719.
[21] 杨锐,韦志强,刘燕霞,等.养阴通络明目方治疗单纯型糖尿病视网膜病变40例临床观察[J].新中医,2014,46(3):123-125.
[22] 朱惠明,江玉,李玲,等.丹红化瘀口服液治疗单纯型糖尿病视网膜病变[J].中国实验方剂学杂志,2013,19(17):320-323.
[23] 高志强.凉血散瘀汤加味治疗瘀热阻络证型非增殖期糖尿病视网膜病变的临床观察[J].中医临床研究,2014,6(22):41-42.
[24] 唐聪.活血通络益气养阴胶囊治疗非增殖期糖尿病视网膜病变临床研究[D].北京:中国中医科学院,2009.
[25] 郝晓楠.达明饮1号治疗糖尿病视网膜病变的临床观察[D].哈尔滨:黑龙江中医药大学,2006.
[26] 宋剑涛.芪明颗粒治疗糖尿病视网膜病变随机、阳性药对照、多中心临床研究[D].成都:成都中医药大学,2004.
[27] 陈晨.糖目宁治疗早期糖尿病视网膜病变的临床及实验研究[D].北京:中国中医科学院,2007.
[28] 李勇.糖网清汤治疗糖尿病视网膜病变60例临床观察[J].河北中医,2011,33(2):255-256.
[29] 姚贤凤.养阴行血法对单纯型糖尿病视网膜病变微循环影响的临床研究[D].贵阳:贵阳中医学院,2012.
[30] 王花.达明饮联合羟苯磺酸钙治疗非增殖期糖尿病视网膜病变的临床研究[D].哈尔滨:黑龙江中医药大学,2001.
[31] 孙榕,回世洋.化瘀明目汤治疗不同时期糖尿病视网膜病变疗效对比观察及其对VEGF的影响[J].世界中医药,2016,11(1):75-78.
[32] 郭硕,王伟.疏血通注射液联合羟苯磺酸钙胶囊治疗单纯型糖尿病视网膜病变的疗效观察[J].现代药物与临床,2016,31(6):819-822.
[33] 纪丽君,孙景莹,梁俊芳,等.糖尿病视网膜病变与血糖控制情况临床分析[J].中国实用眼科杂志,2014,32(4):478-480.
[34] 王芳,王春芳,闫建林,等.45岁以上糖尿病患者中糖尿病视网膜病变的患病率调查及相关危险因素分析[J].中华实验眼科杂志,2013,31(8):783-787. |
|
|
|